参考文献/References:
[1]高鹏,王志飞.中国颅内动脉粥样硬化性狭窄介入治疗的现状与未来[J].中国脑血管病杂志,2023,20:289-297.
[2]张继伟,李亮,齐宝柱,等.脑血管侧支循环建立程度预测大脑中动脉狭窄患者支架置入术后转归的价值[J].中华老年心脑血管病杂志,2022,24:124-127.
[3]余莹,娄亚柯,崔荣荣,等.颅内动脉支架内再狭窄的研究进展[J].中国卒中杂志,2021,16:619-624.
[4]Mehran R,Dangas G,Abizaid AS,et al.Angiographic patterns of in-stent restenosis:classification and implications for long-term outcome[J].Circulation,1999,100:1872-1878.
[5]Derdeyn CP,Fiorella D,Lynn MJ,et al.Nonprocedural symptomatic infarction and in-stent restenosis after intracranial angioplasty and stenting in the SAMMPRIS trial (stenting and aggressive medical management for the prevention of recurrent stroke in intracranial stenosis)[J].Stroke,2017,48:1501-1506.
[6]王泽华,高阳.磁共振高分辨力血管壁成像在缺血性脑卒中的研究进展[J].磁共振成像,2023,14:156-160,165.
[7]张雨晴,金海洋,李奎.探讨能谱计算机断层(CT)联合磁共振(MR)高分辨率管壁成像(HR-VWI)对颈动脉斑块成分的评估价值[J].中国CT和MRI杂志,2023,21:55-57.
[8]秦海强,王伊龙.动脉管壁磁共振扫描在缺血性卒中诊疗中的临床价值[J].中国卒中杂志,2017,12:473-476.
[9]吴静静,贾琳,王云玲,等.磁共振血管壁成像对症状性大脑中动脉粥样硬化斑块的定量评估[J].临床放射学杂志,2020,39:2152-2155.
[10]李亚楠,石莹,吴海珊,等.对比增强高分辨率血管壁成像评估不同钆基对比剂对颅内斑块强化效果的差异[J].磁共振成像,2023,14:79-84.
[11]Wang CX,Cironi K,Mathkour M,et al.Anatomical study of the posterior spinal artery branches to the medulla oblongata[J].World Neurosurg,2021,149:e1098-e1104.
[12]赵新宇,朱良付.颅内动脉粥样硬化性狭窄血管内支架成形术后支架再狭窄相关危险因素的研究进展[J].介入放射学杂志,2023,32:1150-1155.
[13]Alurkar A,Karanam LSP,Oak S,et al.Role of balloon-expandable stents in intracranial atherosclerotic disease in a series of 182 patients[J].Stroke,2013,44:2000-2003.
[14]Shin YS,Kim BM,Suh SH,et al.Wingspan stenting for intracranial atherosclerotic stenosis:clinical outcomes and risk factors for in-stent restenosis[J].Neurosurgery,2013,72:596-604.
[15]马敏敏,殷勤,徐格林,等.Wingspan支架治疗症状性颅内动脉狭窄术后再狭窄的相关因素分析[J].中华医学杂志,2011,91:1303-1307.
[16]Peng G,Zhang Y,Miao Z.Incidence and risk factors of in-stent restenosis for symptomatic intracranial atherosclerotic stenosis:a systematic review and meta-analysis[J].AJNR Am J Neuroradiol,2020,41:1447-1452.
[17]Ran Y,Wang Y,Zhu M,et al.Higher plaque burden of middle cerebral artery is associated with recurrent is chemic stroke:a quantitative magnetic resonance imaging study[J].Stroke,2020,51:659-662.
[18]高鹏.颅内动脉粥样硬化性狭窄影像学评价专家共识[J].中国脑血管病杂志,2021,18:575-584.
[19]Lin GH,Song JX,Fu NX,et al.Quantitative and qualitative analysis of atherosclerotic stenosis in the middle cerebral artery using high-resolution magnetic resonance imaging[J].Can Assoc Radiol J,2021,72:783-788.
[20]Tian B,Zhu C,Tian X,et al.Baseline vessel wall magnetic resonance imaging characteristics associated with in-stent restenosis for intracranial atherosclerotic stenosis[J].J Neurointerv Surg,2023,15:288-291.
[21]Luo J,Li L,Wang T,et al.Risk factors of new cerebral infarctions after endovascular treatment for basilar artery stenosis based on high-resolution magnetic resonance imaging[J].Front Neurol,2020,11:620031.
[22]任婷.高分辨率磁共振颅内血管壁成像在脑梗死中的应用进展[J].现代医药卫生,2018,34:3659-3662.
[23]Teng Z,Peng W,Zhan Q,et al.An assessment on the incremental value of high-resolution magnetic resonance imaging to identify culprit plaques in atherosclerotic disease of the middle cerebral artery[J].Eur Radiol,2016,26:2206-2214.
[24]Song JW,Pavlou A,Xiao JY,et al.Vessel wall magnetic resonance imaging biomarkers of symptomatic intracranial atherosclerosis:a meta-analysis[J].Stroke,2021,52:193-202.
[25]杨丽,王效春.高分辨率磁共振血管壁成像在缺血性脑卒中的应用进展[J].磁共振成像,2022,13:136-139.
[26]Zhang DF,Wu XY,Zhang WD,et al.The relationship between patterns of remodeling and degree of enhancement in patients with atherosclerotic middle cerebral artery stenosis:a high-resolution MRI study[J].Neurol India,2021,69:1663-1669.
[27]Won SY,Cha J,Choi HS,et al.High-resolution intracranial vessel wall MRI findings among different middle cerebral artery territory infarction types[J].Korean J Radiol,2022,23:333-342.
[28]李文君,刘俊艳.高分辨率磁共振成像与颅内动脉粥样硬化性疾病的诊断[J].中华神经科杂志,2015,48:711-714.
[29]Zhao J,Lu Y,Cui J,et al.Characteristics of symptomatic plaque on high-resolution magnetic resonance imaging and its relationship with the occurrence and recurrence of ischemic stroke[J].Neurol Sci,2021,42:3605-3613.
[30]Hu F,Yu S,Li J,et al.Association between hyperhomocysteinemia combined with metabolic syndrome and higher prevalence of stroke in Chinese adults who have elevated blood pressure[J].Med Sci Monit,2022,28:e934100.
[31]Ranjana P.Hyperhomocysteinemia is an emerging comorbidity in ischemic stroke[J].Exp Neurol,2021,336:113541.
[32]邱梓峰,卢宇轩,孙永安,等.高同型半胱氨酸血症对缺血性脑卒中影响的研究进展[J].中华老年心脑血管病杂志,2023,25:879-881.
[33]Huang S,Cai J,Tian Y.The prognostic value of homocysteine in acute ischemic stroke patients:a systematic review and meta-analysis[J].Front Syst Neurosci,2020,14:600582.
[34]Wang X,Cao Q,Lai Y,et al.Association between plasma total homocysteine levels and risk of early hemorrhagic transformation in patients with acute ischemic stroke:a hospital-based study[J].J Stroke Cerebrovasc Dis,2021,30:105538.
[35]Kim KY,Shin KY,Chang KA.Potential biomarkers for post-stroke cognitive impairment:a systematic review and meta-analysis[J].Int J Mol Sci,2022,23:602.
相似文献/References:
[1]吕惠生,牛惠敏,晁苑翔,等.血管支架成形术治疗症状性大脑中动脉狭窄[J].介入放射学杂志,2010,(03):227.
LHuisheng,NIU Huiming,CHAO Yuanxiang,et al.Stent angioplasty for the treatment of symptomatic stenosis of middle cerebral artery[J].journal interventional radiology,2010,(12):227.